hVIVO is a clinical research organisation based in the United Kingdom that specialises in human challenge studies, in which healthy volunteers are exposed to infectious diseases in controlled settings so that experimental medicines and vaccines can be tested. It runs these trials for pharmaceutical and biotechnology companies developing treatments for respiratory and other viral infections, and it also offers related laboratory and clinical services. Its work supports clients in the life sciences sector seeking early evidence on how well a candidate product performs.
hVIVO plc trades under the code HVO on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #3151 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
15/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-22.5%
From 52-week high-43.4%
MomentumWeak
22/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-17.2%
6-month return-27.0%
12-month, skipping last month-5.7%
Stability (higher is calmer)Weak
21/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)67.5%
Worst drawdown, 1 year (smaller is calmer)-44.4%
LiquidityStrong
72/100
Trades actively.
See the numbers →
Avg daily value traded8.41M GBX
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends3
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 4.305 – 11.000Daily closes, split-adjusted
Signals
50-day average6.279
200-day average7.159
Golden/death cross (60d)Death, 45 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.361
Technical summary
Daily
Strongly bearish
3 bullish · 1 neutral · 12 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
5.78
Bearish
EMA 10
5.75
Bearish
SMA 20
5.90
Bearish
EMA 20
5.90
Bearish
SMA 50
6.28
Bearish
EMA 50
6.24
Bearish
SMA 100
6.79
Bearish
EMA 100
6.62
Bearish
SMA 200
7.16
Bearish
EMA 200
7.33
Bearish
Oscillators (daily)
RSI (14)
35.70
Neutral
MACD (12, 26)
-0.20
Bearish
Momentum (12)
-9.02
Bearish
Stochastic %K (14)
16.67
Bullish
Williams %R (14)
-83.33
Bullish
CCI (20)
-168.2
Bullish
Pivot points (classic, last session)
S3
5.10
S2
5.25
S1
5.40
Pivot
5.55
R1
5.70
R2
5.85
R3
6.00
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.00 GBP
Yield on today's price
–
Frequency
None in the last year
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
0.0020
0.0020
0.0045
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in GBX. Educational only, not financial advice.
